Cargando…
An outbreak of deaths associated with AMB-FUBINACA in Auckland NZ
BACKGROUND: AMB-FUBINACA is a synthetic cannabinoid that has been associated with periodic outbreaks of acute poisonings, but few fatalities. In late May, June and July 2017 Auckland, New Zealand, experienced an outbreak of deaths associated with AMB-FUBINACA that continued at a rate of about 2–3 pe...
Autores principales: | Morrow, Paul L, Stables, Simon, Kesha, Kilak, Tse, Rexson, Kappatos, Diana, Pandey, Rishi, Russell, Sarah, Linsell, Oliver, McCarthy, Mary Jane, Spark, Amy, Vertes, Dianne, Triggs, Yvonne, McCarthy, Sinead, Cuthers, Nanise, Massey, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385440/ https://www.ncbi.nlm.nih.gov/pubmed/32743487 http://dx.doi.org/10.1016/j.eclinm.2020.100460 |
Ejemplares similares
-
Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications
por: Lobato-Freitas, Carolina, et al.
Publicado: (2021) -
In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats
por: Fabregat-Safont, David, et al.
Publicado: (2022) -
Characterisation of AMB-FUBINACA metabolism and CB(1)-mediated activity of its acid metabolite
por: Webb, Hunter D. J., et al.
Publicado: (2022) -
Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11
por: Kevin, Richard C., et al.
Publicado: (2022) -
Analysis of AMB-FUBINACA Biotransformation Pathways in Human Liver Microsome and Zebrafish Systems by Liquid Chromatography-High Resolution Mass Spectrometry
por: Xu, Duo-qi, et al.
Publicado: (2019)